S Mbua Efange

Title: S Mbua Efange: Innovator in Pharmaceutical Chemistry

Introduction

S Mbua Efange is a notable inventor based in Plymouth, MN (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target monoamine re-uptake and cholinergic function in mammals. With a total of 3 patents, his work has implications for treating various diseases.

Latest Patents

Among his latest patents are the "Spiroindanamines and Spiroindanimides," which are compounds designed to inhibit monoamine re-uptake. These compounds, along with their pharmaceutically acceptable salts, are useful for treating diseases where insufficient synaptic levels of monoamine are implicated. Additionally, he has developed "Decahydroquinoline-based anti-cholinergic agents," which exhibit anticholinergic activity and are beneficial for modulating cholinergic function in mammals. Both patents also disclose pharmaceutical compositions and processes for preparing these compounds.

Career Highlights

S Mbua Efange has worked at prestigious institutions such as the University of Minnesota and the University of Miami. His research has focused on innovative solutions in the pharmaceutical industry, contributing to advancements in drug development and therapeutic applications.

Collaborations

He has collaborated with notable colleagues, including Deborah Carmen Mash and Stanley M Parsons, enhancing the scope and impact of his research through teamwork and shared expertise.

Conclusion

S Mbua Efange's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of new therapeutic agents.